Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Elmer who wrote (5473)	1/18/2002 7:42:00 PM
From: scott_jiminez	Respond to of 52153

You should consider a third possibility: That IMCL was less than forthcoming, to put it extremely mildly, with the scope of FDA's letter of late December. Specifically, there appears to have been a good deal of deception by omission by ImClone regarding the degree of insufficiency of their application...AND the time, effort and expense required to accommodate these glaring deficiencies. This really appears to be an Enron-type lesson: it's not a conspiracy of the government or anything remotely of the sort. This has the appearance of a massive bungling on the part of ImClone...that may put the very sustainability of the company at risk. This is my opinion alone. I am neither a shareholder nor am I related to anyone associated with the company, its lawyers, or (especially) its accountants. I do have an ongoing relationship with my Dachshund, Willy, however.